TABLE 1.
Patient characteristicsa
| Characteristic | Value for the following patients: |
P value | |
|---|---|---|---|
| Cases (n = 116) | Controls (n = 114) | ||
| No. (%) of male patients | 64 (55.2) | 69 (60.5) | 0.491 |
| Median (IQR) age (yr) | 64 (55, 73) | 59 (43, 67) | 0.002 |
| No. (%) of patients infected with HIV | 13 (11.2) | 8 (7.0) | 0.382 |
| Median (IQR) CD4+ T cell count (no. of cells/µl) | 35.5 (7, 106) | 69 (0.5, 172.5) | 0.879 |
| Median (IQR) lymphocyte count (no. of cells/µl) | 400 (200, 800) | 500 (200, 950) | 0.459 |
| Median (IQR) LDH level (fraction of the upper limit of normal) | 1.52 (1.15, 2.13) | 1.01 (0.74, 1.35) | <0.001 |
| No. (%) of patients with the following underlying disease or condition: | |||
| Hematologic malignancy | 26 (22.4) | 39 (34.2) | |
| Solid tumor | 25 (21.6) | 12 (10.5) | |
| Solid organ transplant | 17 (14.7) | 11 (9.6) | |
| Allogeneic HSCT | 15 (12.9) | 25 (21.9) | |
| HIV infection | 13 (11.2) | 8 (7.0) | |
| Other | 20 (17.2) | 19 (16.7) | |
| No. (%) of patients alive at: | |||
| Wk 6 | 68 (58.6) | 88 (77.2) | 0.004 |
| Wk 12 | 62 (53.4) | 79 (69.3) | 0.020 |
a
IQR, interquartile range; HSCT, hematopoietic stem cell transplantation; HIV, human immunodeficiency virus; LDH, lactate dehydrogenase.